Bispecific antibodies are the next-generation monoclonal antibodies that recognize and bind to 2 different antigens to exert their effect. The Food and Drug Administration approved the first bispecific antibody, blinatumomab, for relapsed or refractory acute lymphoblastic leukemia treatment in 2014. Since then, 9 more bispecific antibodies have received FDA approval and are currently in clinical use. Bispecific antibodies have produced good clinical responses. However, these agents have unique toxicity profiles.This activity for healthcare professionals is designed to enhance learners’ competence in evaluating and managing bispecific antibody toxicity. Participants gain a deeper understanding of the condition’s pathophysiology, varied presentations, preventive measures, and diagnostic and management strategies. Learners become prepared to work within an interprofessional team caring for patients with bispecific antibody toxicity.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/148519
- Start Date: 2024-12-01 06:00:00
- End Date: 2024-12-01 06:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.0 Point; Credit Type(s): Lifelong Learning (ABA)
ABTS - 1.0 Point; Credit Type(s): Accredited CME (ABTS)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
ABTS - 1.0 Point; Credit Type(s): Self-Assessment (ABTS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: All Practice Areas (e.g. ethics), Ambulatory/Outpatient, Cardiovascular Disease, Complex General Surgical Oncology, Critical Care Medicine, General Operative Anesthesia, General Pediatrics, General Surgery, General Thoracic, Hematology, Hospital Medicine, Infectious Disease, Internal Medicine, Medical Oncology, Medical Toxicology, Nephrology, Neurocritical Care, Pediatric Critical Care Medicine, Pediatric Emergency Medicine, Pediatric Hematology-Oncology, Pediatric Infectious Diseases, Pediatric Neurology, Pulmonary Disease, Surgical Critical Care